Medicis Pharmaceutical Corp (NYSE:MRX)

CAPS Rating: 5 out of 5

A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.

Results 1 - 20 of 20

Recs

0
Member Avatar pbk100 (29.75) Submitted: 6/8/2011 12:01:45 PM : Outperform Start Price: $36.03 MRX Score: -32.50

Magic Formula + Insider buying

Recs

0
Member Avatar coryjobe (93.45) Submitted: 7/24/2010 4:53:24 PM : Outperform Start Price: $23.30 MRX Score: +2.52

Due to high demand of Triaz, Ziana, and Solodyn sales have been up and should continue to keep going up. They also have a strong group of products to help reduce acne. Medics continue to spend a lot of time and money to develop new products and improve their already strong list of products, this should help them keep increasing their earnings in the future. They currently have a great balance sheet, with a lot of cash and not much debt, this could be used for a number of different things but most likely will be used to increase their R&D.

Recs

0
Member Avatar kenc132000 (96.59) Submitted: 3/18/2009 11:39:33 AM : Outperform Start Price: $8.84 MRX Score: +236.04

New 52 week low. Double down on losing position.

Recs

0
Member Avatar sandvig (99.46) Submitted: 12/24/2008 11:17:47 AM : Outperform Start Price: $13.42 MRX Score: +93.63

Going long on pimples and wrinkles. They cover the bases from teens to pre-geezers.

Recs

0
Member Avatar trovak79 (< 20) Submitted: 10/2/2008 12:43:54 PM : Outperform Start Price: $13.90 MRX Score: +135.08

Cash/share = price

Recs

0
Member Avatar comet9 (< 20) Submitted: 7/13/2008 6:37:25 PM : Outperform Start Price: $18.02 MRX Score: +79.99

Slowed growth in earnings due to increased expenses with LipoSonix acquisition. Whether that business takes off or not, there is very good value here.

Recs

0
Member Avatar NASAGeek (89.91) Submitted: 6/26/2008 9:21:56 PM : Outperform Start Price: $19.25 MRX Score: +68.27

magicformulainvesting.com screen at $153M market cap, top 25 companies on June 26, 2008

Recs

1
Member Avatar Richthofen80 (90.19) Submitted: 6/22/2008 12:41:30 PM : Outperform Start Price: $20.30 MRX Score: +60.87

Pure speculation on the Liposonix acquisition. Surgery free fat removal has huge potential if FDA approves. If not, at least they get international exposure because the process is already approved in Europe.

Recs

0
Member Avatar angus118 (< 20) Submitted: 5/14/2008 5:27:31 PM : Outperform Start Price: $21.96 MRX Score: +53.82

magic formula pick. buy@22.78 and check in a year.

Recs

0
Member Avatar Colli002 (79.28) Submitted: 5/6/2008 6:50:13 AM : Outperform Start Price: $19.35 MRX Score: +79.66

Biotechnology play - great intrinsic value ratio

Recs

0
Member Avatar Smiley81 (< 20) Submitted: 4/29/2008 10:56:48 AM : Outperform Start Price: $19.46 MRX Score: +77.61

$25+/share

Recs

0
Member Avatar MD4Beauty (< 20) Submitted: 11/13/2007 5:48:42 PM : Underperform Start Price: $26.63 MRX Score: -25.19

Medicis has been given a strong buy recommendation by Standard and Poor's analysts citing their new products for acne treatment and their strong market share in dermal fillers (Restylane and Perlane). From someone in the trenches of treating acne, I have been underwhelmed by the new Ziana and Solodyne products. These don't seem like the right fuel to launch a rocket to soaring profits. The Restylane product will be getting more competition from Juvederm and Radiesse as well as other dermal fillers in the pipeline.

Recs

0
Member Avatar Mroczka11 (91.47) Submitted: 10/11/2007 4:18:54 PM : Outperform Start Price: $27.05 MRX Score: +28.24

Reloxin filing in Q4 plus Ziana and Perlane growth will drive earnings and stock higher.

Recs

0
Member Avatar 3PO (84.91) Submitted: 10/6/2007 11:10:00 AM : Outperform Start Price: $28.67 MRX Score: +18.97

S&P Fair Value @28.50

Recs

1
Member Avatar Ludraman1 (< 20) Submitted: 9/20/2007 1:28:36 PM : Outperform Start Price: $29.18 MRX Score: +13.31

dermatology products treating acne, acne-related conditions, fungal

infections, skin discoloration, and inflammatory and hyperproliferative skin diseases, such as psoriasis

and topical dermatitis.

People are increasingly concerned with appearance and willing to spend more money on anything that affects the skin.

Medical spending continues in a downturn too.

Recs

0
Member Avatar btincher (49.12) Submitted: 7/7/2007 5:43:19 AM : Outperform Start Price: $29.58 MRX Score: +11.66

New, fairly affordable skin product now widely available. Replaces surgery for those who can't afford a plastic surgeon. Profits should take place by 4th quarter.

Recs

0
Member Avatar BaeslerCapital (< 20) Submitted: 5/5/2007 7:11:54 PM : Outperform Start Price: $29.53 MRX Score: +9.23

Vanity play for all those retiring bankers.

you know who you are...

Recs

0
Member Avatar nickbaes (66.05) Submitted: 2/1/2007 2:40:20 PM : Outperform Start Price: $34.95 MRX Score: -20.78

Vanity play for the baby boomers.
expected to earn 1.64 this coming year.
22 x that number is good considering where I feel that eps number is heading.

Recs

1
Member Avatar justdoodleit (< 20) Submitted: 12/3/2006 4:28:58 PM : Outperform Start Price: $35.14 MRX Score: -25.72

Focuses primarily on helping patients attain a healthy and youthful appearance and self-image through the development and marketing of products for the treatment of dermatological and aesthetic conditions in the U.S. and Canada.

fillers for wrinkles - baby boomers vanity

seems like a good entry for now - at bottom of uptrend - got killed in May bear market, so beware

Recs

4
Member Avatar continentala (< 20) Submitted: 9/3/2006 8:10:48 PM : Outperform Start Price: $28.33 MRX Score: -6.38

The cure for AIDS is yet to come. Part of this is the virus replicates its RNA in every victim so fast that scientists can't keep up. One of the results of the disease is appearance of wasting away in the face. Medicis has defeloped a product specifically for this to eliminate the appearance, not cure it. Hollywood has gotten on the ban wagon and is using it because the product lasts longer than other fillers. But even in the most capable hands, the results can look strange if not properly executed.

Results 1 - 20 of 20

Featured Broker Partners


Advertisement